Mark J Ratain

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 12

Top Topics

Sickle Cell Disease

Prefrontal Cortex

Juvenile Idiopathic Arthritis

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

JCO oncology practice

JCO precision oncology

Journal of the National Cancer Institute

This page only lists publications with an associated author ORCID identifier.

Publications

Garth W Strohbehn, Allen S Lichter, Mark J Ratain
US Government Payer-Funded Trials to Address Oncology's Drug-Dosing Conundrum: A Congressional Call to Action? Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Garth W Strohbehn, Mark J Ratain
Special designations and the US Food and Drug Administration's "dual mandate". Journal of the National Cancer Institute (2023)
Austin Wesevich, Monica E Peek, Mark J Ratain
An Ethical and Financial Obligation for Sickle Cell Disease Gene Therapy in the United States. Annals of internal medicine (2023)
Austin Wesevich, Daniel A Goldstein, Koosha Paydary, Cody J Peer, William Douglas Figg, Mark J Ratain
Interventional pharmacoeconomics for immune checkpoint inhibitors through alternative dosing strategies. British journal of cancer (2023)
Sofia I Jacobson, Alec J Kacew, Randall W Knoebel, Po-Hung Hsieh, Mark J Ratain, Garth W Strohbehn
Alternative Trastuzumab Dosing Schedules Are Associated With Reductions in Health Care Greenhouse Gas Emissions. JCO oncology practice (2023)
Mark J Ratain
Designing Dose-Finding Phase I Clinical Trials: Top Questions That Should Be Discussed With Your Clinical Pharmacologist. JCO precision oncology 5 (2022)
Apostolos Papachristos, Mark J Ratain
Lurbinectedin-induced thrombocytopenia: the role of body surface area. Cancer chemotherapy and pharmacology 89 (5) (2022)
Mark J Ratain
Oncology Drug Prescribing: The Influences of Greed and Fear. JCO oncology practice 18 (9) (2022)
Mark J Ratain, Ian F Tannock, Allen S Lichter
Dose Optimization of Sotorasib: Is the US Food and Drug Administration Sending a Message? Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (31) (2021)
Natalie M Reizine, Keith Danahey, Emily Schierer, Ping Liu, Merisa Middlestadt, Jenna Ludwig, Tien M Truong, Xander M R Van Wijk, Kiang-Teck Jerry Yeo, Monica Malec, Mark J Ratain, Peter H O'Donnell
Impact of CYP2D6 Pharmacogenomic Status on Pain Control Among Opioid-Treated Oncology Patients. The oncologist 26 (11) (2021)
Ian F Tannock, Mark J Ratain, Daniel A Goldstein, Allen S Lichter, Gary L Rosner, Leonard B Saltz
Near-Equivalence: Generating Evidence to Support Alternative Cost-Effective Treatments. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (9) (2021)
Garth W Strohbehn, Brian L Heiss, Sherin Juliet Rouhani, Jonathan A Trujillo, Jovian Yu, Alec J Kacew, Emily F Higgs, Jeffrey C Bloodworth, Alexandra Cabanov, Rachel C Wright, Adriana Koziol, Alexandra Weiss, Keith Danahey, Theodore G Karrison, Cuoghi C Edens, Iazsmin Bauer Ventura, Natasha N Pettit, Bhakti Patel, Jennifer Pisano, Mary E Strek, Thomas F Gajewski, Mark J Ratain, Pankti D Reid
COVIDOSE: Low-dose tocilizumab in the treatment of Covid-19. medRxiv : the preprint server for health sciences (2020)